Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,906 | 213 | 75.3% |
| Travel and Lodging | $1,352 | 2 | 20.7% |
| Education | $199.90 | 2 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57.64 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,433 | 9 | $0 (2019) |
| ABBVIE INC. | $1,020 | 37 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $869.09 | 23 | $0 (2024) |
| Genentech USA, Inc. | $832.06 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $245.61 | 6 | $0 (2020) |
| UCB, Inc. | $233.94 | 5 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $171.49 | 7 | $0 (2019) |
| Eisai Inc. | $150.44 | 3 | $0 (2024) |
| PFIZER INC. | $144.63 | 8 | $0 (2024) |
| Lundbeck LLC | $133.04 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $861.58 | 42 | Eisai Inc. ($150.44) |
| 2023 | $358.30 | 25 | ABBVIE INC. ($151.22) |
| 2022 | $842.10 | 22 | ABBVIE INC. ($666.49) |
| 2021 | $139.62 | 5 | Genentech USA, Inc. ($139.62) |
| 2020 | $72.46 | 4 | GENZYME CORPORATION ($19.83) |
| 2019 | $981.06 | 37 | Novartis Pharmaceuticals Corporation ($227.06) |
| 2018 | $2,353 | 67 | LivaNova USA, Inc. ($1,187) |
| 2017 | $907.29 | 18 | Teva Pharmaceuticals USA, Inc. ($438.45) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Neuropsychiatry | ||||||
| 10/18/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neuropsychiatry | ||||||
| 08/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Immunology | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Neurology | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.18 | General |
| Category: NEUROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEUROLOGY | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,644 | 2,728 | $653,863 | $241,368 |
| 2022 | 24 | 1,629 | 2,120 | $648,731 | $221,235 |
| 2021 | 22 | 1,425 | 1,827 | $643,873 | $225,352 |
| 2020 | 23 | 1,266 | 1,596 | $464,513 | $162,454 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 377 | $79,170 | $32,853 | 41.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 103 | 697 | $69,700 | $32,048 | 46.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 61 | 64 | $40,000 | $21,193 | 53.0% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 97 | 97 | $49,858 | $15,366 | 30.8% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 81 | 81 | $42,039 | $13,389 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 104 | $27,040 | $13,233 | 48.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 65 | 192 | $35,280 | $13,120 | 37.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 67 | 67 | $26,867 | $12,977 | 48.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 96 | 96 | $34,560 | $10,947 | 31.7% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 85 | 85 | $40,375 | $10,458 | 25.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 46 | 46 | $26,220 | $8,422 | 32.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 51 | 52 | $19,240 | $8,130 | 42.3% |
| 95714 | Measurement of brain wave activity with video (veeg), 12-26 hours | Office | 2023 | 18 | 52 | $52,000 | $7,948 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $16,380 | $7,464 | 45.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 73 | 74 | $15,762 | $7,091 | 45.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 74 | 118 | $8,850 | $4,130 | 46.7% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2023 | 17 | 17 | $7,956 | $3,843 | 48.3% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 73 | 148 | $9,324 | $3,730 | 40.0% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 19 | 19 | $19,000 | $2,594 | 13.7% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 18 | 18 | $6,498 | $2,083 | 32.1% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 73 | 74 | $4,662 | $1,811 | 38.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 19 | 19 | $6,726 | $1,761 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 26 | $3,900 | $1,495 | 38.3% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 19 | 19 | $2,470 | $1,254 | 50.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 19 | 19 | $3,230 | $1,166 | 36.1% |
About Dr. Ijaz Rashid, M.D
Dr. Ijaz Rashid, M.D is a Neurology healthcare provider based in Auburn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1003138058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ijaz Rashid, M.D has received a total of $6,515 in payments from pharmaceutical and medical device companies, with $861.58 received in 2024. These payments were reported across 220 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,906).
As a Medicare-enrolled provider, Rashid has provided services to 5,964 Medicare beneficiaries, totaling 8,271 services with total Medicare billing of $850,409. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Auburn, NY
- Active Since 02/18/2010
- Last Updated 07/29/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003138058
Products in Payments
- VNS Therapy (Device) $1,433
- UBRELVY (Drug) $694.36
- OCREVUS (Biological) $353.60
- AUSTEDO (Drug) $295.78
- Briviact (Drug) $233.94
- QULIPTA (Drug) $231.52
- Ocrevus (Biological) $228.23
- AJOVY (Drug) $210.30
- NUPLAZID (Drug) $171.49
- Leqembi (Drug) $150.44
- MAYZENT (Drug) $147.42
- COPAXONE (Drug) $144.59
- NURTEC ODT (Drug) $139.70
- TROKENDI XR (Drug) $124.18
- VYEPTI (Biological) $112.83
- TYSABRI (Biological) $101.39
- BRIUMVI (Drug) $94.93
- INGREZZA (Drug) $85.97
- Non-Covered Product (Drug) $85.76
- ACTHAR (Biological) $85.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Auburn
Mitchell Ross, Md, MD
Neurology — Payments: $102,416
Jianxin Ma, M.d, M.D
Neurology — Payments: $13,709
Kanwardeep Grewal, M.d, M.D
Neurology — Payments: $7,099
Gregory Dardas, Md, MD
Neurology — Payments: $5,972
Dr. Minna Hancock, D.o, D.O
Neurology — Payments: $5,064
Dr. Paul Fu, M.d, M.D
Neurology — Payments: $4,489